Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Edderd who wrote (5643)	2/24/1998 11:12:00 AM
From: Upstater	Respond to of 23519

VIVUS got upgraded at Zacks to a hold: VVUS 12.5625 0.1250 849400 3 + Zacks likely raised the rating because some house raised VVUS last night/this morning and has only informed in house clients as of yet. In my experience, ZACKS changes usually proceed movements in the price of VVUS. In this case expect an upgrade soon.

To: Edderd who wrote (5643)	2/24/1998 1:22:00 PM
From: EyeDrMike	Read Replies (1) \| Respond to of 23519

<<Mike, Those are nice observations and categories of patients but not reality. Most of the time the doc is not going to be able to make that critical determination that this patient cannot be treated with Viagra.>> Sorry, i think you're absolutely wrong here. Its the doctor's legal, moral, and ethical responsibility to give safe treatment to a patient based on their systemic medical history, and the problem they present with at the time of the exam. I believe most doctors will look at patients with hypertension and diabetes, not to mention other systemic problems, such as pulmonary and renal disease, for example, and will be very hesitant to prescribe a systemic drug. Regardless of what the labelled contraindications or PFE says about their product. Mike